Please assess the completion status of the following clinical trial:

Trial Title: Genetic Study of Familial Forms of Non-atopic Asthma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* index case:~  * Major~ * Lack of respiratory disease documented in the medical record other than asthma~ * Severe Asthma by definition ATS / ERS 2014:~* Treatment with high doses of CI and beta2 agonists for long-acting (B2LDA) or anti leukotriene or theophylline during the previous year or oral corticosteroids (CO) more than 50% from the previous year to prevent loss of control asthma.~* Asthma uncontrolled (at least 1 criteria):~  * ACT \<20 and / or ACQ\> 1.5 (Asthma Control Test)~ * 2 courses or more CO in the previous year~ * 1 hospitalization for asthma in the previous year~ * FEV \<80% predicted despite bronchodilators.~* Examination or medical record to find at least one member of the genetically non-atopic asthma associated family~* Prick negative tests for common allergens, questionnaire seeking negative atopy (SFAR Love) Phadiatop or negative diagnosis of non-atopic asthma confirmed by the adjudication committee~* informed and written consent of the patient to participate in the study~* Affiliated to a social security scheme~Exclusion Criteria:~* Pregnant women~* Minors~  - Known associated respiratory pathologies (COPD, bronchial dilatation, diffuse infiltrating pneumopathy)~* Major Trust~* Subject having demonstrated the inability or refusal to sign an informed consent~Relatives' patients:~* Major~* Related to the 1st and 2nd level of the index case or another member with family~* Related with or without a asthma (atopic or non-atopic)~* Informed and written consent of the patient to participate in the study Affiliated to a social security scheme~Exclusion Criteria:~* Pregnant women~* Minors~* Major Trust~* Subject having demonstrated the inability or refusal to sign an informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- blood sample for genetic evaluation (Type: OTHER): a blood sample is collected once for genetic analysis

Based on this trial design, predict the completion outcome and termination type (if applicable).